Outpatient-Based Therapy of Oral Fludarabine and Subcutaneous Alemtuzumab for Asian Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Background. Intravenous alemtuzumab and fludarabine are effective in combination for the treatment of chronic lymphocytic leukemia (CLL), but require hospital visits for intravenous injection. We performed a pilot study to assess the safety and efficacy of outpatient-based oral fludarabine with subc...

ver descrição completa

Detalhes bibliográficos

Principais autores:	William Y. K. Hwang, Claire Dearden, Yvonne S. M. Loh, Yeh C. Linn, Sim L. Tien, Gerrard K. H. Teoh, Gee F. How, Kee K. Heng, Yeow T. Goh, Lai H. Lee
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2009-01-01
Colecção:	Advances in Hematology
Acesso em linha:	http://dx.doi.org/10.1155/2009/547582
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!